Evidence map›Paper›PMID 40517144›Full record

ArticleNPJ digital medicine2025

Large scale causal modeling to identify adults at risk for combined and common variable immunodeficiencies.

Giorgos Papanastasiou, Marco Scutari, Raffi Tachdjian, Vivian Hernandez-Trujillo, Jason Raasch, Kaylyn Billmeyer, Nikolay V Vasilyev, Vladimir Ivanov

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Giorgos Papanastasiou *Pfizer Inc., New York, NY, USA. georgios.papanastasiou@pfizer.com.
Marco Scutari *Istituto Dalle Molle di Studi sull'Intelligenza Artificiale (IDSIA), Lugano, Switzerland.ORCID http://orcid.org/0000-0002-2151-7266
Raffi TachdjianDivision of Allergy & Clinical Immunology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.
Vivian Hernandez-TrujilloAllergy & Immunology Care Center of South Florida, Miami Lakes, FL, USA.
Jason RaaschMidwest Immunology Clinic, Plymouth, MN, USA.
Kaylyn BillmeyerPfizer Inc., New York, NY, USA.
Nikolay V VasilyevPfizer Inc., New York, NY, USA.
Vladimir IvanovPfizer Inc., New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Combined immunodeficiencies (CID) and common variable immunodeficiencies (CVID), prevalent yet substantially underdiagnosed primary immunodeficiencies, necessitate improved early detection. Leveraging large-scale electronic health records (EHR) from four nationwide US cohorts, we developed a novel causal Bayesian Network (BN) model to identify antecedent clinical phenotypes associated with CID/CVID. Consensus directed acyclic graphs (DAGs) demonstrated robust predictive performance within each cohort (ROC AUC: 0.61-0.77) and generalizability across unseen cohorts (ROC AUC: 0.56-0.72) in identifying CID/CVID, despite varying inclusion criteria across cohorts. The consensus DAGs reveal causal relationships between comorbidities preceding CID/CVID diagnosis, including autoimmune and blood disorders, lymphomas, organ damage or inflammation, respiratory conditions, genetic anomalies, recurrent infections, and allergies. Further evaluation through causal inference and by expert clinical immunologists substantiates the clinical relevance of the identified phenotypic trajectories. These findings hold promise for translation into improved clinical practice, potentially leading to earlier identification and intervention of adults at risk for CID/CVID.

Identifiers

PMID40517144
PMCPMC12167375

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.